BallingerJ.R., BannemanJ., BoxenI., FirbyP., BerryB.W., HartmanN.G., MooreM.J.: 99mTc-tetrofosmin as a substrate for P-glycoprotein: in vivo studies in multidrug-resistant breast tumor cells. J. Nucl. Med., 37: 1578–1581, 1996.
2.
BasogluT., SahinM., CoskunC., KoparanA., BernayI., ErkanL.: 99mTc-tetrofosmin uptake in malignant lung tumours. Eur. J. Nucl. Med., 22: 687–689, 1995.
3.
BassettL.W., Kimme-SmithC.: Breast sonography. AJR156: 449–455, 1991.
4.
ButlerJ., VarjasH., WorthenN., WilsonS.: Accuracy of combined clinical-mammographic-cytologic diagnosis of dominant breast masses: a prospective study. Arch. Surg., 125: 893–896, 1990.
GoliaR., MilettoP., SpadaforaM., De RiminiM.L., De GennaroS., MazzarellaG., CaraccioloF., MansiL.: An improved technique for mammary scintigraphy in patients with breast cancer. J. Nucl. Biol. Med., 38: 236–237, 1994.
7.
HarmsS.E., FlamingD.P., HesleyK.L., HarmsS.E., FlamingD.P., HesleyK.L., MeichesM.D., JensenR.A., EvansW.P., SavinoD.A., WellsR.V.: MR imaging of the breast with rotating delivery of excitation of resonance: clinical experience with pathological correlation. Radiology, 187: 493–501, 1993.
8.
JonesS., HendelR.C.: Technetium-99m tetrofosmin: a new myocardial perfusion agent. J. Nucl. Med. Technol., 21: 191–195, 1993.
9.
KhalkhaliI., CutroneJ., MenaI., DigglesL., VenegasR., VargasH., JacksonB., KleinS.: Technetium-99m-sestaMIBI scintimammography of breast lesions: clinical and pathological follow-up. J. Nucl. Med., 36: 1784–1789, 1995.
10.
KhalkaliI., CutroneJ.A., DigglesL., MishkinF.: The role of nuclear medicine imaging for the evaluation of patients with breast abnormalities. In: Nuclear medicine annual, FreemanL.M., pp. 113–141, Lippincott JB Company, Philadelphia, 1996.
11.
KosudaS., YokoyamaH., KatayamaM., YokoKawaT., KusanoS., YamamotoO.: 99mTc tetrofosmin and 99mTc sestaMI-BI imaging of multiple metastases from differentiated thyroid carcinoma. Eur. J. Nucl. Med., 22: 1218–1220, 1995.
12.
MansiL., RambaldiP.F., MarinoG., PecoriB., Del VecchioE.: Kinetics of 99mTc sestaMIBI and 99mTc tetrofosmin in a case of parathyroid adenoma. Clin. Nucl. Med., 21: 700–703, 1996
13.
MansiL., RambaldiP.F., LaproviteraA., Di GregorioF., ProcacciniE.:Tc-99m tetrofosmin uptake in breast tumors. J. Nucl. Med., 36: 83P, 1995.
14.
MansiL., RambaldiP.F., ProcacciniE., Di GregorioF., LaproviteraA., PecoriB., Del VecchioW.: Scintimmammography with 99mTc tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Eur. J. Nucl. Med., 23: 932–939, 1996
15.
PlattsE.A., NorthT.L., PickettR.D., KellyJ.D.: Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization. J. Nucl. Card., 4: 317–326, 1995.
16.
RambaldiP.F., MansiL., ProcacciniE., Di GregorioF., Del VecchioE.: Breast cancer detection with Tc-99m tetrofosmin. Clin. Nucl. Med., 20: 703–705, 1995.
17.
RechtA., SadowskyN.L., CadyB.: Clinical problems in follow-up of patients following conservative surgery and radiotherapy. Surg. Clin. North Am., 70: 1179–1186, 1990.
18.
RosenP.P.: The pathology of invasive breast carcinoma. In: Breast diseases, HarrisJ.R., HellmanS., HendersonI.C., KinneD.W., Eds., pp. 245–296, JB Lippincott Company, Philadelphia, 1991.
19.
TailleferR., BoucherY., PotvinC., LambertR.: Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with 99mTc-sestaMIBI (double phase study). J. Nucl. Med., 33: 1801–1807, 1992.
20.
TailleferR., RobidouxA., LambertR., TurpinS., LaperriereJ.: Technetium-99m-sestaMIBI prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J. Nucl. Med., 36: 1758–1765, 1995.
